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Abstract 
The pluripotency factor OCT4 is essential for the maintenance of naïve pluripotent stem cells 
in vitro and in vivo. However, the specific role of OCT4 in this process remains unknown. 
Here, we developed a rapid protein-level OCT4 depletion system that demonstrates that the 
immediate downstream response to loss of OCT4 is reduced expression of key pluripotency 
factors. Our data show a requirement for OCT4 for the efficient transcription of several key 
pluripotency factors, and suggest that expression of trophectoderm markers is a subsequent 
event. Additionally, we find that NANOG is competent to bind to the genome in the absence 
of OCT4, and this binding is in fact enhanced. Globally, however, active enhancer 
associated histone mark H3K27ac is depleted. Our work establishes that while OCT4 is 
required for the maintenance of the naïve transcription factor network, at a normal ESC level 
it antagonises this network through inhibition of NANOG binding. 
  
3 of 26 
 
Introduction 
Naïve pluripotent stem cells (nPSCs) are the embryonic founders of the cells present in the 
adult animal. The transcription factor OCT4, expressed from the gene Pou5f1, is necessary 
for the maintenance of naïve pluripotency in vivo and in vitro. In both cases, loss of OCT4 
ultimately leads to exit from naïve pluripotency and with cells taking on characteristics of the 
trophoblast lineage, including expression of marker genes Cdx2, Pl-1 and Eomes, and 
adoption of trophectoderm-like morphology (Nichols et al., 1998; Niwa et al., 2000). 
Despite this, it is not understood why OCT4 is essential to the naïve state; OCT4 is a highly 
promiscuous transcription factor, binding to thousands of sites in the genome (King and 
Klose, 2017; Simandi et al., 2016), and many of its target genes are known not to be 
essential for the maintenance of nPSCs (Hall et al., 2009; Matoba et al., 2006; Zwaka, 
2012). At the same time, no target has been identified that can rescue OCT4-loss driven 
differentiation either through overexpression or knockout (Hall et al., 2009; Matoba et al., 
2006). It therefore seems likely that differentiation upon loss of OCT4 is the result of 
misregulation of a number of genes rather than of any single critical target. 
Studying the effects of loss of OCT4 are further complicated by the fact that OCT4 appears 
to function in a level-dependent manner (Niwa et al., 2000). Mouse nPSCs engineered to 
express reduced levels of OCT4 are recalcitrant to differentiation and in some cases can be 
maintained in minimal culture conditions (Karwacki-Neisius et al., 2013; Radzisheuskaya et 
al., 2013), including basal serum-free media devoid of otherwise essential growth factors 
and inhibitors of differentiation pathways. Expression of pluripotency associated genes may 
be enhanced in this state, and responses to signalling cues may be altered. In particular, it 
appears that transcript and protein levels of the core pluripotency factor Nanog are 
negatively correlated with OCT4 expression (Karwacki-Neisius et al., 2013). 
NANOG is a homeodomain transcription factor that co-binds with OCT4 at many enhancers 
to promote expression of other pluripotency genes (Chen et al., 2008; Loh et al., 2006). 
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While NANOG is not absolutely required for maintenance of the naïve identity (Chambers et 
al., 2007), loss of NANOG results in widespread differentiation and reduced self-renewal 
capacity (Chambers et al., 2007; Ivanova et al., 2006; Mitsui et al., 2003). Interestingly, 
binding of NANOG to the genome appears to be enhanced in self-renewing nPSCs 
expressing low levels of OCT4, in line with the increased overall level of NANOG protein 
(Karwacki-Neisius et al., 2013; Radzisheuskaya et al., 2013), while during differentiation 
induced by loss of OCT4 NANOG binding is reduced (King and Klose, 2017). However, the 
immediate effect of total loss of OCT4 protein on NANOG binding to the genome remains 
unknown. 
Conventional methods for depleting OCT4, such as genetic ablation via Lox-Cre systems or 
transcriptional repression using Tet-OFF regulated transgenes, rely on natural degradation 
to remove Oct4 mRNA and protein. A result of this is that OCT4 persists for a long time. 
Consequently, responses to depletion of OCT4 are typically examined on the order of hours 
to days following manipulation (Hall et al., 2009; Niwa et al., 2000), making it impossible to 
discern whether results are related to OCT4 or simply to cells undergoing differentiation. 
Further complicating such analysis, microarray data have revealed changes in the 
expression of thousands of genes at early timepoints after OCT4 suppression, even as the 
majority of OCT4 protein remains (Hall et al., 2009). This means that such variation may 
represent a response to a change in OCT4 expression to lower than WT levels, previously 
described to enhance self-renewal capacity in nPSCs (Karwacki-Neisius et al., 2013; 
Radzisheuskaya et al., 2013). Thus, the nature of the essential role of OCT4 for the self-
renewal of nPSCs remains elusive. 
In order to overcome these confounding factors, we generated an OCT4 fusion protein to a 
full length auxin-inducible degron. This allows us to induce rapid protein-level depletion of 
OCT4 making it possible for the first time to study the immediate molecular responses to 
loss of OCT4. These revealed an unprecedented impact on the transcriptional activity of 
pluripotency-associated transcription factor genes and addressed a long-standing question 
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regarding the requirement of OCT4 for the binding of a key pluripotency factor, NANOG, to 
regulatory sequences. 
Results 
Auxin-degron tagged OCT4 sustains naïve PSC self-renewal and permits rapid loss of 
OCT4 
OCT4 protein has a relatively long half-life; unlike pluripotency factor NANOG with a 
reported half-live of around 3 hours, the half-life of OCT4 protein is typically found to be >6 
hours to as much as 24 hours (Abranches et al., 2013; Muñoz Descalzo et al., 2013). 
Additionally, the endogenous Oct4 mRNA also appears to be unusually stable in mouse 
ESCs (Abranches et al., 2013). Indeed, we found that conventional tamoxifen-induced 
CreER driven genetic ablation of Pou5f1 resulted in a gradual reduction, and required over a 
day to fully deplete Oct4 RNA and protein (Figure 1A-B). Four days after induction, cells 
showed distinct morphological changes, resembling trophoblasts and more differentiated 
trophectodermal cells (Figure S1A). This shows that genetic and transcriptional methods of 
silencing Oct4 take a long time to fully deplete OCT4 protein, and cells are likely to 
experience a protracted period of low OCT4 content. Given the transcriptional and 
phenotypic effects previously observed in cells stably expressing low levels of OCT4 
(Karwacki-Neisius et al., 2013; Radzisheuskaya et al., 2013), this is likely to have 
confounding effects on studies of immediate responses to complete removal of OCT4. We 
therefore decided to utilize a full length auxin-inducible degron (AID) tag (Baker et al., 2016; 
Nishimura et al., 2009) to achieve rapid, inducible protein-level degradation of OCT4 on 
addition of the small molecule IAA. 
Since OCT4 is essential for the maintenance of pluripotency we sought to confirm that AID-
tagged OCT4 retained its biological function by testing its capacity to support ESCs lacking 
wild-type OCT4. We utilized an existing TetOFF-Oct4 cell line; non-functional transgenes 
cannot rescue self-renewal on dox-induced inhibition of wild-type OCT4 in these cells (Niwa 
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et al., 2002), allowing them to be used in a complementation assay. We generated Oct4-/- 
TetOFF-Oct4 Oct4-AID ESCs (O4AID ESCs hereafter) by transfecting these cells with 
constitutively expressed Piggybac Oct4-AID and NLS-Tir1 constructs and maintained cells in 
the presence of doxycycline to inhibit expression of wild-type OCT4 (Figure 1C). Cells 
continued to proliferate and showed normal morphology (Figure S1B). Cells expressed the 
fusion protein with no detectable wild-type OCT4 present, and did not show substantially 
altered expression of key pluripotency genes (Figure 1D-E). This demonstrates that the 
OCT4 fusion protein retains its original capacity to maintain naïve pluripotency and is not 
substantially altered in its function by the addition of the AID domain. 
To further validate the function of OCT4 within the fusion protein and to establish a second 
independent cell system, we generated iPSCs null for endogenous OCT4 and therefore 
wholly reliant on either transgenic wild-type OCT4 or OCT4-AID for their maintenance 
(Figure 1F). After a period of outgrowth, cells initiated reprogramming and generated 
intermediate pre-iPSCs (Silva et al., 2008; Theunissen et al., 2011) with high expression of 
retroviral reprogramming factors but very low expression of the pluripotency factor Nanog 
(Figure 1G). Under naïve-specific conditions, colonies with a domed, iPS-like morphology 
were readily obtained using either wild-type or Oct4-AID constructs (Figure S1C). Nanog 
was robustly expressed while retroviral transgenes were efficiently silenced in the fully 
reprogrammed iPSCs (Figure 1G). Again, as expected wild-type OCT4 was not detectable 
while the OCT4-AID fusion protein was robustly expressed (Figure 1H). Furthermore, in 
differentiation conditions cells showed loss of pluripotency markers and upregulation of 
markers of all three germ layers, indicating competency to initiate normal differentiation 
(Figure S1D).The ability of the Oct4-AID transgene to maintain pluripotency in this OCT4 
knockout background further demonstrates that the essential function of OCT4 is 
maintained. 
Utilizing the new protein degradation system, tagged OCT4 protein levels could be greatly 
reduced within half an hour and undetectable within two hours of addition of IAA (Figure 
7 of 26 
 
1E&H). This quick turnover means that there is no appreciable OCT4-low state, and we 
therefore sought to use this system to study immediate responses of cells to total loss of 
OCT4. 
OCT4 is required for the expression of key pluripotency factors 
We analysed gene expression changes following conventional tamoxifen-induced CreER-
driven genetic ablation of Pou5f1 (Figure 2A and Figure S2A). The results indicate that while 
specific pluripotency-associated genes such as Nr0b1 are downregulated within 24hrs after 
induction of OCT4 depletion, upregulation of trophoblast-associated genes occurs 
concurrently with expression of most naïve pluripotency factors; overall the pluripotency 
network remains expressed for 24hrs. In keeping with previous observations, however, many 
of these gene expression changes are detected while significant amounts of OCT4 protein 
are still present (Figure 1B). This is consistent with reports that expression of pluripotency 
genes may be enhanced in cells with reduced levels of OCT4 (Karwacki-Neisius et al., 2013; 
Radzisheuskaya et al., 2013), supporting the notion that conventional methods of OCT4 
depletion pass through a protracted OCT4-low state, complicating interpretation of the 
effects of removal of OCT4. 
In contrast to the above, analysis of O4AID cells indicated that expression of naïve-
associated factors is quickly extinguished on loss of OCT4 (Figure 2B and Figure S2C-D). 
Factors such as Tfcp2l1, Klf4 and Tbx3 are rapidly downregulated following targeted OCT4 
protein depletion whereas they were actively maintained in the slower conventional system.  
Examining several trophoblast-associated genes confirmed that these cells exit pluripotency 
following loss of OCT4 and differentiate towards trophectodermal lineages (Figure 2B and 
Figure S2C-D), in keeping with conventional OCT4 depletion systems. However, strong 
upregulation of trophectoderm associated genes is only seen after a decrease in 
pluripotency marker expression using this system, indicating that the decision to enter this 
extraembryonic identity is made only after cells have begun to exit the naïve state. Analysis 
of eGFPAID ESCs validated that neither loss of pluripotency gene expression nor 
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upregulation of trophectoderm markers were caused by IAA itself, nor activation of TIR1-
induced proteasomal degradation (Figure S2B).  
Together these altered kinetics in transcriptional responses highlight that there are important 
differences between gradually reducing OCT4 protein levels and removing OCT4 protein 
entirely.  
Enhancers show rapid epigenetic and functional inactivation following loss of OCT4 
Given the rapid downregulation of pluripotency-associated genes, we examined how 
enhancer elements were affected by loss of OCT4 at a number of these loci. Enhancer-
associated transcription can be observed at many active enhancers (Kim et al., 2010; De 
Santa et al., 2010), and can play a functional role in promoting transcription of target genes 
(Alvarez-Dominguez et al., 2017; Shii et al., 2017). We observed loss of transcription from 
several pluripotency enhancer elements shortly after ablation of OCT4 (Figure 3A), implying 
loss of enhancer activity. 
To validate this, we looked at the level of acetylation of histone H3 at lysine residue 27 
(H3K27ac), a mark closely associated with active enhancers. Using ChIP-seq, we observed 
a dramatic decrease in H3K27ac at pluripotency-associated enhancers (Figure 3B and 
Figure S3A), and we confirmed this using ChIP-qPCR in both O4AID ES and O4AID iPS 
systems (Figure S3B-C). Again, we examined eGFPAID ESCs, and found no change in 
H3K27ac levels at pluripotency-associated enhancers following application of IAA, 
demonstrating that this response is specifically a response to OCT4 depletion (Figure S3B-
C). Loss of H3K27ac was not restricted to pluripotency-associated loci, however; global 
analysis of all H3K27ac peaks showed a significant decrease (Figure 3C). Using peaks 
called from OCT4 ChIP-seq data generated by (Marson et al., 2008), we examined if this 
was the result of decommissioning of OCT4-cobound enhancers; while the reduction in 
H3K27ac signal was stronger at sites close to OCT4 binding sites, H3K27ac peaks that were 
not directly bound by OCT4 still showed a marked reduction, indicating a remarkable shift in 
the global chromatin landscape in the absence of OCT4. 
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OCT4 is dispensable for NANOG binding to pluripotent regulatory sequences 
Depletion of OCT4 was so rapid that protein levels of other pluripotency factors were not 
strongly affected by the time OCT4 protein was fully removed; NANOG protein levels were 
only slightly reduced (Figure 4A and Figure S4C). As a result, we decided to use this 
opportunity to examine changes in the chromatin binding profile of NANOG, a transcription 
factor that binds to many of the same enhancer elements as OCT4. 
NANOG binding efficiency at the enhancer of the Nanog and Pou5f1 genes was analysed by 
ChIP-qPCR. Surprisingly in both O4AID ES and iPS systems, NANOG not only remained 
bound but there was greater NANOG signal following depletion of OCT4 (Figure 4B and 
Figure S4D). Interestingly, other work has suggested that in the OCT4-low state NANOG 
has increased genomic occupancy, though OCT4 was still present (Karwacki-Neisius et al., 
2013; Radzisheuskaya et al., 2013). We validated that Oct4AID was effectively depleted by 
immunoprecipitating OCT4 from sheared chromatin, followed by Western Blotting. While we 
could readily pull down Oct4AID from uninduced samples, it was almost undetectable even 
in the chromatin-enriched eluate in IAA treated samples (Figure S4A). In the data presented 
here we actively avoid the presence of OCT4, suggesting that either directly or indirectly 
OCT4 actively reduces the ability of NANOG to bind to enhancer elements.  
We therefore examined the NANOG binding profile at the regulatory regions of several key 
pluripotency genes using ChIP-seq. There was a clear increase in NANOG binding at 
several loci following depletion of OCT4 (Figure 4C). Interestingly, expression of these 
genes is decreased following induced OCT4 degradation despite the increased NANOG 
binding (Figure 2B and Figure S2C-D). Of particular note, the Klf4 distal enhancer element 
showed greater NANOG signal following loss of OCT4, yet reduced mRNA and enhancer 
RNA expression, and H3K27 acetylation (Figure 2B, Figure S2C-D, Figure 3A-B and Figure 
S3B-C). This further highlights that the presence of OCT4 appears to be absolutely required 
for the expression of certain pluripotency-associated genes. 
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NANOG binding is increased globally, independent of OCT4 co-binding 
We further analysed our NANOG ChIP-seq data to examine global changes in NANOG 
binding immediately following OCT4 ablation. Looking at all NANOG binding sites revealed a 
global shift towards greater levels of NANOG enrichment (Figure 5A and B). Examining the 
change in NANOG signal over all peaks, there is a significant overall increase following loss 
of Oct4 (16608 NANOG peaks; paired t-test of NANOG signal before and after treatment, p 
< 10-10; t-test of log fold change of thresholded peaks vs 4458 sub-threshold (background) 
peaks, p < 10-10). To investigate whether the effect on NANOG binding was specific to sites 
where OCT4 co-binds, we looked at the complementary subsets of NANOG peaks less than 
1kb from an OCT4 peak (3930 sites) and those that do not co-bind with OCT4 (12678 sites), 
again using peaks called from OCT4 ChIP-seq data from (Marson et al., 2008) (Figure 5B). 
At OCT4-NANOG co-binding sites there was a detectable increase in NANOG signal; 
globally this was statistically significant (paired t-test of NANOG signal before and after 
treatment, p < 10-10; t-test of log fold change of thresholded peaks vs 382 sub-threshold 
(background) peaks, p < 10-10), though surprisingly the magnitude of the increase was 
reduced compared to all NANOG peaks. NANOG peaks that do not overlap with OCT4 
displayed a more dramatic increase in NANOG binding (12678 peaks; paired t-test of 
NANOG signal before and after treatment, p < 10-10; t-test of log fold change of thresholded 
peaks vs 4076 sub-threshold (background) peaks, p < 10-10), suggesting that the reduced 
NANOG binding in the presence of OCT4 is not directly due to physical occlusion of NANOG 
binding sites by OCT4 or due to changes in local chromatin structure in the 
presence/absence of OCT4. One possible explanation for this global effect is an increase in 
the stability of NANOG protein following loss of OCT4; however, it has previously shown that 
NANOG displays increased stability in the presence of OCT4 (Muñoz Descalzo et al., 2013). 
In keeping with this, we determined the half-life of NANOG with or without addition of IAA 
which revealed a decrease from ~ 2.3 hours in the presence of OCT4 to ~ 1.4 hours in the 
absence of OCT4 (Figure S5A). This suggests that stability is not the cause of the increased 
genomic occupancy of NANOG that we observed. 
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We additionally examined the effect of chromatin context on the change in NANOG binding 
following loss of OCT4. We used publicly available ChIP-seq data to classify 2861 NANOG 
peaks as enhancer- promoter- and/or repressive mark associated. As expected, the majority 
of these NANOG peaks were associated with enhancers (Figure 5C). In all cases, there was 
a significant increase in NANOG signal (Figure 5D; paired t-test, p < 10-10) and the mean 
increase in signal was comparable, suggesting that the chromatin context has little impact on 
the ability of OCT4 to restrict NANOG binding under normal conditions. 
Discussion 
It has been shown that OCT4 is dispensable for initial generation of the blastocyst structure, 
but required for segregation of the inner cell mass into naïve epiblast and primitive 
endoderm (Le Bin et al., 2014). OCT4 is also essential for maintaining naïve pluripotency in 
vitro (Niwa et al., 2000). Despite this, the manner in which OCT4 is required for these 
processes is unclear; no overexpression or knockout mutants that rescue the OCT4 
knockout phenotype have been identified (Hall et al., 2009; Matoba et al., 2006; Niwa et al., 
2000). In order to infer how OCT4 mediates self-renewal, we wanted to examine initial 
transcriptional changes in response to OCT4 depletion. It is notable that similar experiments 
have been performed before (Hall et al., 2009; Matoba et al., 2006) and have failed to yield 
an essential role for OCT4. However, it is known that cells exhibiting a low level of OCT4 can 
sustain expression of pluripotency markers under mild differentiation conditions (Karwacki-
Neisius et al., 2013; Radzisheuskaya et al., 2013), and we wondered if transcription of such 
factors was being artificially maintained by the gradually reducing level of OCT4 protein in 
conventional depletion systems. The half-life of OCT4 is sometimes reported to be very long 
(Lin et al., 2012; Wei et al., 2007); it took a full day for OCT4 to be fully removed from 
Pou5f1F/- cells used in this work (Figure 1A-B), and published work shows more than 10 
hours for complete OCT4 depletion using a TetOFF system (Hall et al., 2009; Niwa et al., 
2000). This is a significant amount of time, especially since transcriptional changes are 
already observed within this window. In order to avoid this confounding factor, we 
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established new cell lines utilising rapid depletion of OCT4 at the protein level (Figure 1C-H). 
It has previously been reported that the auxin-inducible degron can reduce the half-life of 
tagged proteins to ~20 minutes in mammalian systems (Holland et al., 2012; Nishimura et 
al., 2009), and indeed we found that tagged OCT4 protein was greatly reduced within half an 
hour and fully depleted within 1.5-2 hours (Figure 1E&H). After ensuring that both the AID 
domain and OCT4 were unaltered in their function in this fusion protein (Figure 1D&G and 
Figure S1B-C), we proceeded to re-examine the immediate effects of loss of OCT4. Since 
depletion of OCT4 was so rapid, we were able to examine the effect of loss of OCT4 prior to 
extensive changes in the protein level of other pluripotency transcription factors. Crucially, 
the high temporal resolution afforded by such a rapid depletion system reveals two phases 
of transcriptional change following loss of OCT4, unlike following genetic ablation (Figure 2). 
First, RNA levels of all pluripotency factors examined were rapidly decreased following 
degradation of OCT4 protein. Notably, all the factors tested display OCT4 binding at their 
enhancer or promoter elements in published ChIP-seq data. This suggests that the presence 
of OCT4 at these elements may be essential for the expression of a broad range of 
pluripotency associated genes, explaining why no single factor can rescue the OCT4 
knockout phenotype. Only subsequently did we observe upregulation of trophectoderm-
associated markers, suggesting that this may be a secondary effect or that derepression of 
these loci occurs over a longer timescale. In keeping with an essential role in permitting 
active transcription, we found a global reduction in the level of H3K27ac, associated with 
active enhancers (Figure 3 and Figure S3). The fact that this loss of active enhancer marks 
extends beyond pluripotency-associated loci could imply that OCT4 is critical for maintaining 
the uniquely permissive chromatin environment found in naïve pluripotent cells, beyond 
simply acting to drive expression of key pluripotency factors. 
ChIP-qPCR and ChIP-seq against NANOG protein yielded an interesting and surprising 
result; in the absence of OCT4, greater levels of NANOG were found bound to the genome 
(Figures 4 and 5, and Figures S4 and 5). Remarkably, this extended beyond OCT4 co-
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bound sites, with an increase in NANOG levels observed at many binding sites lacking 
OCT4 (Figure 5B). Consequently, it seems unlikely that this effect is due to OCT competing 
with NANOG for binding sites, in keeping with previous reports of simultaneous binding of 
OCT4 and NANOG to regulatory regions as detected by sequential ChIP (Medeiros et al., 
2009). A previous study examining the localisation of NANOG and SOX2 24 hours after 
transcriptional depletion of OCT4 found that SOX2 and NANOG binding was reduced at 
many OCT4 co-bound sites following silencing of Oct4 (King and Klose, 2017). However, 
this carries the caveat that such changes may be due to subsequent transcriptional and 
epigenetic changes downstream of loss of OCT4 rather than direct effects. In particular, 
reduced NANOG signal was associated with loss of transcription and chromatin accessibility, 
suggesting that these enhancer elements were no longer active or accessible, perhaps due 
to the onset of differentiation, by the time of their analysis. In contrast, by using a targeted 
protein degradation system we are able to study the immediate changes in protein 
localisation in our system, limiting secondary effects. 
Interestingly, we observed a rapid downregulation of Klf4, an enhancer RNA associated with 
the Klf4 super-enhancer, and loss of the active enhancer histone mark H3K27ac at this 
locus, despite an increase in NANOG binding in this region. It has previously been shown 
that expression of Klf4 is highly dependent on the presence of NANOG, although it can be 
partially rescued with overexpression of ESRRB (Festuccia et al., 2012). However, only 
when NANOG and STAT3 are both present is there efficient transcription of both Klf4 and 
the Klf4 eRNA; neither overexpression of NANOG in the absence of active STAT3, nor 
induction of JAK/STAT signalling in NANOG knockout ESCs are capable of inducing Klf4 or 
Klf4 eRNA upregulation (Stuart et al., 2014). Our findings appear to add OCT4 to this list of 
factors that need to be present to achieve activation of this enhancer region. 
It is currently unclear how the global nuclear structure changes following acute depletion of 
OCT4. Previous work has suggested that OCT4 may act as a pioneer factor, opening 
chromatin that would otherwise be highly compacted (King and Klose, 2017; Soufi et al., 
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2015). As a result, removal of OCT4 might result in the eviction of other transcription factors 
and repression of gene expression, though the increased binding of NANOG to chromatin 
suggests this may not be the case (Figures 4 and 5). Additionally, there could be significant 
changes in the chromatin architecture due to altered topological domains in the absence of 
OCT4. Decommissioning of super enhancers, many of which are bound by OCT4 in ESCs 
(Whyte et al., 2013), could lead to a reorganisation of the nuclear structure as these 
elements interact with multiple promoter regions, even over large distances (Novo et al., 
2018). 
The ability to probe transcriptional responses immediately following total OCT4 depletion, 
and the capacity to examine changes in the binding of NANOG to chromatin prior to 
significant secondary effects has allowed us to go some way to explaining past 
discrepancies in the perceived role of OCT4 in the pluripotency network. As Hall et al. note, 
Nanog has been described as an OCT4 target gene, and there is significant biochemical 
data validating that OCT4 binds to the Nanog enhancer region and is required for its 
expression (Kuroda et al., 2005; Rodda et al., 2005), yet gradual OCT4 depletion appeared 
to have a limited, even positive impact on Nanog mRNA (Figure 2A, Figure S2) (Hall et al., 
2009). We propose that the reason for this is that while OCT4 may be essential for Nanog 
expression, above a minimal level OCT4 negatively regulates the binding of other 
transcriptional activators. Thus, as OCT4 levels drop and cells pass through an OCT4-low 
state, binding of OCT4 to the Nanog enhancer is reduced and other transcription factors can 
be recruited, buffering Nanog expression levels. Once OCT4 is entirely depleted Nanog 
expression falls as the locus is no longer able to be transcribed. 
In agreement with existing literature, it appears that the half-life of NANOG is increased in 
the presence of OCT4 (Figure S5A) (Muñoz Descalzo et al., 2013). As a result, increased 
NANOG stability is not likely to be responsible for the increased genomic occupancy we 
observed. However, it would be interesting to see what other properties of NANOG protein 
are altered in the absence of OCT4, particularly whether changes in the NANOG protein 
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interactome or DNA binding affinity could explain the increase in chromatin binding. 
Differences in post-translational modifications could affect the ability of NANOG to interact 
with DNA and proteins in this way.  
Combining the transcriptional responses to loss of OCT4 with the observed global changes 
in NANOG ChIP signal have led us to a unifying model for the range of phenotypes 
associated with different levels of OCT4 protein in ESCs (Figure 5E). In the absence of 
OCT4 key pluripotency factors cannot be expressed and cells cannot maintain a naïve 
identity. With low levels of OCT4, a threshold is reached such that these factors are able to 
be expressed, and efficient binding by NANOG results in robust transcription of the whole 
naïve network to such an extent that differentiation is compromised. At higher OCT4 levels, 
such as seen in wild-type ESCs and embryos, OCT4 globally supresses the binding of 
NANOG resulting in a weaker transcriptional network. This allows cells to undergo 
differentiation in response to signalling cues. On overexpression of OCT4, it is expected that 
the binding of NANOG to chromatin will be further reduced, destabilizing the naïve network 
to the point that it cannot be readily maintained. 
In summary, utilizing a rapid protein-level depletion strategy, we identified that the primary 
transcriptional response to loss of OCT4 is a decrease in the expression of pluripotency-
associated genes, and upregulation of trophectoderm factors is a subsequent event. 
Additionally, we found a global increase in the amount of NANOG associated with the 
genome in the absence of OCT4, suggesting a mechanism by which wild-type levels of 
OCT4 ensure that naïve cells retain the capacity to initiate differentiation in response to 
appropriate signals. Together, these reveal a model that ties together the range of 
phenotypes associated with differing levels of OCT4, concisely explaining how different 
levels of this factor result in seemingly contradictory cell behaviours. 




Mouse ESCs were cultured in 2iL conditions as previously described. Briefly, cells were 
maintained in N2B27 (1:1 DMEM/F-12 and Neurobasal, 2mM L-glutamine, 1x penicillin-
streptomycin, 0.1mM 2-mercaptoethanol, 1% B27, 0.5% N2) supplemented with 3μM 
CHIR99021, 1μM PD0325901 and 20ng/ml mLIF. Where stated cells were transitioned into 
SL conditions, consisting of GMEM without L-glutamine, 10% fetal bovine serum, 1x non-
essential amino acids, 1mM sodium pyruvate, 2mM L-glutamine, 1x penicillin-streptomycin, 
0.1mM 2-mercaptoethanol, and 20ng/ml mLIF. ES and iPS cells were maintained on gelatin-
coated tissue culture plastic, NSCs were maintained on laminin-coated tissue culture plastic. 
Cells were passaged every 2-4 days using accutase as required. Where described, media 
was supplemented with 500nM 4-OHT, 1μg/ml doxycycline, and/or 500μM indole-3-acetic 
acid. 
Cell Lines 
Oct4F/- ESCs (Oct4F/β-geo) were previously derived from a cross between Oct4+/β-geo and 
Oct4F/F mice. O4AID ESCs were generated by transfecting ZHBTc4 ESCs (Niwa et al., 2000) 
with pPB-CAG-Oct4AID-PGK-Hph (mouse Oct4 tagged at the C-terminus with full length 
AID, separated by a short PG linker) and pPB-CAG-Tir1-IRES-Bsd (Oryza sativa Tir1, with 
an N-terminal SV40 NLS signal, codon optimized for expression in mouse) with pPBase to 
achieve efficient integration, and maintained in the presence of Doxycycline to silence the 
TetOFF-Oct4 transgene. O4AID iPSCs were generated from Oct4-/- NSCs (Radzisheuskaya 
et al., 2013) nucleofected with pPB-CAG-Oct4AID-PGK-Hph and pPBase to achieve efficient 
integration and reprogrammed; equivalent wild-type Oct4 control cells were generated by 
nucleofection with pPB-CAG-Oct4-PGK-Hph and pPBase. The generated O4AID iPSCs 
were transfected with pCAG-Tir1-IRES-Bsd and clonal lines were assessed for functional 
transgene integration. eGFP-AID ESCs were generated by transfecting Oct4F/- ESCs with 
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pPB-CAG-eGFPAID-IRES-Zeo (eGFP tagged at the C-terminus with full length AID, 
separated by a short PG linker) and pPB-CAG-Tir1-IRES-Bsd with pPBase. 
Reprogramming 
PLAT-E cells were transfected with pMXs-Oct4, pMXs-Klf4 or pMXs-cMyc using FuGENE 6 
reagent to produce retroviral particles. Medium was changed the following day and after 48 
hours supernatant containing retroviral particles was collected. Media were filtered and 
mixed together in equal ratio, then polybrene was added to a final concentration of 4μg/ml. 
The polybrene/virus mixture was applied to NSCs. 24 hours later, NSCs were nucleofected 
with a 1:5 ration of pPBase and either pPB-CAG-Oct4AID-PGK-Hph or pPB-CAG-Oct4-
PGK-Hph using Amaxa Nucleofection Technology and plated in NSC medium for 2 days 
then switched to SL medium. Medium was then switched to KSR-2iL (GMEM without L-
glutamine, 10% KOSR, 1% fetal bovine serum, 1x non-essential amino acids, 1mM sodium 
pyruvate, 2mM L-glutamine, 1x penicillin-streptomycin, 0.1mM 2-mercaptoethanol, and 
20ng/ml mLIF). Selection was applied for expression from the endogenous Oct4 locus on the 
ninth day in KSR-2iL. Once colonies had expanded they were passaged into 2iL conditions. 
Conventional Differentiation 
iPSCs were induced to differentiate either in monolayer differentiation (N2B27) or in 
suspension (embryoid body). For monolayer differentiation, 130k cells were plated in a 
gelatin-coated well of a 6-well plate in 2iL media. The following day this media was removed, 
the wells were washed with N2B27 lacking CHIR99021, PD0325901, and LIF, and cells 
were cultured in N2B27 alone for the duration of the timecourse.  For suspension 
differentiation, 570k cells were transferred to a low-attachment 6cm dish in serum-based 
medium lacking LIF. Cells were allowed to aggregate and expanded in suspension for the 
duration of the timecourse. Media was changed by gently centrifuging floating aggregates 
and transferred back to the low-attachment dish. 
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qRT-PCR and RNA-seq 
Total RNA was isolated from cultured cells using the RNeasy Mini Kit (Qiagen) according to 
the manufacturer’s instructions including on-column DNaseI digest. For RT-qPCR, RNA was 
reverse-transcribed using SuperScript III First-Strand Synthesis SuperMix for RT-qPCR and 
reactions were performed on a StepOnePlus Real time PCR system with recommending 
settings using TaqMan Fast Universal PCR Mix or Fast SYBR Green Master Mix. See 
Supplemental Experimental Procedures for primers and Taqman probes. 
For high throughput RNA sequencing, RNA integrity was assessed on a Qubit Fluorometer 
(ThermoFisher Scientific) and Agilent Bioanalyzer Nano Chips (Agilent Technologies). 
Depletion of ribosomal RNA was performed on 2-5μg of total RNA using the Ribo-Zero rRNA 
Removal Kit (Illumina) and libraries were produced from 10-100ng of ribosomal-depleted 
RNA using NextFlex Rapid Directional RNA-seq Kit (Bio Scientific) with 12 cycles of PCR 
amplification. Libraries were pooled in equimolar quantities and sequenced on the 
HiSeq4000 platform (Illumina) at CRUK. Library preparation was performed by the W-MRC 
CSCI genomics facility. Reads were aligned to mouse genome reference GRCm38/mm10 
with TopHat2 (Kim et al., 2013) v2.1.0 (https://ccb.jhu.edu/software/tophat) using default 
parameters for paired end reads. Gene-wise counts were generated using featureCounts 
(Liao et al., 2014) based on annotation from Ensembl GRCm38.86 release. Transcript 
counts were TMM normalized and differentially expressed genes were called using a non-
parametric algorithm specifically intended for use with data lacking replicates, with q>0.9 
using NOISeq-sim from NOISeq (Tarazona et al., 2011, 2015) version 2.30.0. For all 
NOISeq analyses, the following parameters were used: pnr=0.2, nss=5, v=0.02; seed ‘321’ 
was used for each analysis. 
Western Blot 
Cells were lysed in RIPA buffer (Sigma) containing Complete-ULTRA protease-inhibitor and 
PhoStop phosphatase-inhibitor cocktails (Roche), and sonicated with Bioruptor200 
(Diagenode) at high frequency, alternating 30 s on/off for 3 min. SDS-PAGE electrophoresis 
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was performed using Bolt 10% Bis-Tris Plus gels (ThermoFisher) in a Novex MiniCell 
(ThermoFisher). Protein transfer was performed using the semi-dry iBlot2 system 
(ThermoFisher) and iBlot Transfer Stacks (ThermoFisher). Detection was achieved using 
HRP-linked secondary antibodies diluted 1:10000 against the appropriate species (GE 
Healthcare) and ECL Plus Western Blotting Detection System (GE Healthcare). See 
Supplemental Experimental Procedures for primary antibodies. 
Protein half-life analysis 
Cells were treated with cycloheximide with or without addition of IAA, and harvested at 
hourly intervals. Western blot analysis of Nanog protein levels were performed, and a 
relative standard curve was included using a 1 in 2 dilution series with 4 points from the 
uninduced sample. Western blots were quantitated using Image Studio Lite Quantification 
Software. 
ChIP-qPCR and ChIP-seq 
ChIP was performed as previously described (Radziseuskaya et al., 2013). For detailed 
protocols see Supplemental Experimental Procedures. Chromatin was analysed by qPCR 
using a StepOnePlus Real time PCR system with recommending settings and Fast SYBR 
Green Master Mix. Additionally, next generation sequencing libraries were prepared using 
the ThruPLEX DNA-Seq Kit. Libraries were pooled in equimolar quantities and sequenced 
on the HiSeq4000 platform (Illumina) at CRUK. Library preparation was performed by the W-
MRC CSCI genomics facility. Reads were aligned to mouse genome reference 
GRCm38/mm10 using Bowtie 2 (Langmead and Salzberg, 2012) version 2.3.4.3 with default 
parameters and deduplicated using SAMtools rmdup. For details of next generation 
sequencing analysis, see Supplemental Experimental Procedures. 
ChIP-Western Blot 
ChIP was performed as above, except that a single 40 minute elution was performed. 
Instead of overnight reverse-crosslinking, sample loading buffer and reducing agent were 
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added to the eluate, and samples were boiled for 40 minutes to denature protein and reverse 
crosslinks. Western blot was then performed as described above. 
Data availability 
All sequence data generated during this study are accessible under GEO accession number: 
GSE168579.  
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Figure legends 
Figure 1. Auxin-degron tagged OCT4 sustains naïve PSC self-renewal and permits rapid 
loss of OCT4. 
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A&B) Kinetics of OCT4 depletion in conventional Oct4Fl/- ESCs were examined. A) Oct4 
expression level (RT-qPCR) following addition of 4-OHT and media change to SL. B) OCT4 
protein level (Western blot) following addition of 4-OHT and media change to SL. α-
TUBULIN shown as a loading control. C) Schematic showing the generation and use of 
O4AID ESCs. D) Expression profiling (RT-qPCR) of pluripotency markers. E) Oct4-AID 
fusion and wild-type OCT4 protein level (Western blot) following addition of IAA. α-tubulin 
loading control. F) Schematic showing the generation and use of O4AID iPSCs. rOKM, 
retroviral Oct4, Klf4 and cMyc. G) Expression profiling (RT-qPCR) of retroviruses and 
pluripotency factor Nanog in partially and fully reprogrammed cells. r.Oct4 – retroviral Oct4; 
r.cMyc – retroviral cMyc; r.Klf4 – retroviral Klf4. H) Oct4-AID fusion and wild-type protein 
level (Western blot) following addition of IAA. RT-qPCR data represent mean ± SD of three 
technical replicates. See also Figure S1. 
Figure 2. OCT4 is required for the expression of key pluripotency factors 
MA plots showing gene expression (RNA-seq) changes following A) deletion of Pou5f1 in 
conventional Oct4F/- CreER ESCs by addition of 4-OHT or B) degradation of OCT4 protein in 
O4AID ESCs by addition of IAA. Differentially expressed genes highlighted in green (q > 0.9, 
NOISeq-sim). Selected pluripotency (blue) and differentiation (red) associated genes 
indicated. A) top to bottom: 0 vs 12, 0 vs 18, 0 vs 24, and 0 vs 36 hours respectively. B) top 
to bottom: 0 vs 1.5, 0 vs 6, 0 vs 10, and 0 vs 24 hours respectively. Note that for Oct4F/- 
CreER ESCs two replicate datasets were merged and for O4AID ESCs a single replicate 
was used. A non-parametric algorithm designed for use on data lacking replicates was used 
for the analysis (see Experimental procedures for more details). Key findings were 
corroborated by RT-qPCR analysis in two independent cell lines, see Figure S2. 
Figure 3. OCT4 is required for enhancer activity at key pluripotency loci, and for maintaining 
global H3K27ac 
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A) Mapped RNA-seq reads (single replicate) of enhancer RNAs at the Prdm14 distal 
enhancer (top) and the Klf4 distal enhancer (bottom) in O4AID ESCs before and 1.5 hours 
after addition of IAA. B) ChIP-seq analysis of H3K27ac at the Prdm14 distal enhancer (top) 
and the Klf4 distal enhancer (bottom) in O4AID ESCs before and 1.5 hours after addition of 
IAA. Genomic coordinates refer to the GRCm38/mm10 genome assembly, and gene 
intron/exon annotations are taken from Ensembl. OCT4 binding sites generated from ChIP-
seq data from Marson et al. 2008 indicated in purple. C) Violin and box plot showing log2-
fold change in H3K27ac signal between uninduced and 1.5 hour IAA treated O4AID ESCs. 
Data were generated by merging mapped ChIP-seq reads from 3 independent IPs. Note that 
the key findings were corroborated by ChIP-qPCR in two independent cell lines (Figure 
S3B). Boxes show the median value and extend to the 25th and 75th quartiles, and whiskers 
extend to 1.5 times the interquartile range. Plotted are all H3K27ac peaks (n=26457) above 
a (background) threshold, and the complementary subsets of peaks within 1kb of an OCT4 
binding site (n=4662) and not within 1kb of an OCT4 binding site (n=21795). For each set a 
paired t-test of H3K27ac signal before and after treatment showed highly significant change, 
p < 10-10. See also Figure S3. 
Figure 4. OCT4 is dispensable for NANOG binding to pluripotent regulatory sequences 
A) Protein level of OCT4 and NANOG (Western blot) in O4AID ESCs before and 1.5 hours 
after addition of IAA with α-tubulin as a loading control. B) ChIP qPCR following pulldown of 
NANOG or using normal IgG negative control at NANOG binding sites or a negative control 
locus in O4AID ESCs. ChIP qPCR data for NANOG pulldown represent the mean ± SD of 
three IPs; IgG pulldown represents the mean of three technical replicates of single IP. ND = 
not detected. Note that this is corroborated by ChIP qPCR in an independent cell line (Figure 
S4). C) Visualization of NANOG ChIP-seq signal (SPKM) across indicated loci before and 
1.5 hours after addition of IAA, shown for two IPs. Genomic coordinates refer to the 
GRCm38/mm10 genome assembly, and gene intron/exon annotations are taken from 
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Ensembl. OCT4 binding sites generated from ChIP-seq data from Marson et al. 2008 
indicated in purple. See also Figure S4. 
Figure 5. NANOG binding is increased globally, independent of OCT4 co-binding 
A) Summary distribution (top) and heatmap (bottom) of NANOG signal (sum of mapped 
reads from two independent IPs, normalized to library size) at centred at the summit of all 
NANOG binding sites across the genome, before and 1.5 hours after addition of IAA. B) 
Violin and box plot of log2 of the fold change in the average normalized NANOG signal at 
each NANOG peak in the genome (n=16608) before and after addition of IAA, further broken 
down into loci within (n=3930) or further than (n=12678) 1kb of OCT4 binding sites 
generated from ChIP-seq data from Marson et al. 2008. Mapped reads from two 
independent IPs each before and after treatment were merged to generate NANOG ChIP-
seq data. Boxes show the median value and extend to the 25th and 75th quartiles, and 
whiskers extend to 1.5 times the interquartile range. C) Euler plot showing the number of 
NANOG peaks assigned to various chromatin environments, and the overlap between 
assignations. Numbers indicate the number of peaks uniquely in that section of the diagram. 
D) Violin and box plot of log2 of the fold change in the average normalized NANOG signal 
(data as in B) at each NANOG peak in the genome before and 1.5 hours after addition of 
IAA, further broken down into non-exclusive chromatin environments, as indicated in C. 
Boxes show the median value and extend to the 25th and 75th quartiles, and whiskers extend 
to 1.5 times the interquartile range. E) Model indicating the proposed relationship between 
the quantity of OCT4 protein and the capacity for NANOG to bind to the genome and 
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Figure S1. Characterization of cell lines. Relating to Figure 1. 
A) Cells before and after conventional tamoxifen-induced CreER driven genetic ablation of Oct4. 
Uninduced cells grow as compact, round, domed colonies. 4 days after application of tamoxifen, cells 
have attained an enlarged, flattened morphology. Scalebar – 100μm. B) Oct4-/- Tet-OFF Oct4 ESCs (left) 
and O4AID ESCs share similar morphology, with mostly compact, round, domed colonies. Scalebar – 
50μm. C) Oct4-/- NSCs (left) were reprogrammed in the presence of either wild-type Oct4 or Oct4-AID 
fusion protein. In both cases, similar round, domed colonies were formed (right). Scalebar – 100μm. D) 
RT-qPCR analysis of pluripotency and lineage markers following monolayer differentiation (N2B27) and 
suspension differentiation (embryoid body) of O4AID iPS and Oct4 iPSCs. RT-qPCR data represent the 
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Figure S2. Expression changes following induction. Relating to Figure 2. 
RT-qPCR analysis of pluripotency (top) and trophectoderm (bottom) associated genes in Oct4F/- CreER 
ESCs (A), eGFPAID ESCs (B),O4AID ESCs (C), and O4AID iPSCs (D), in a timecourse following induced 






















































































































































































































































































Figure S3. H3K27ac ChIP analysis following induction. Relating to Figure 3. 
A) ChIP-seq analysis of H3K27ac at the Tet1 enhancer (top) and the Tet2 enhancer (bottom) in O4AID 
ESCs before and 1.5 hours after addition of IAA. Genomic coordinates refer to the GRCm38/mm10 
genome assembly, and gene intron/exon annotations are taken from Ensembl. Oct4 binding sites 
generated from ChIP-seq data from Marson et al. 2008 indicated in purple. B&C) ChIP-qPCR analysis of 
H3K27ac at B) the Klf4 distal enhancer and C) the Prdm14 distal enhancer in O4AID ESCs (left), O4AID 
iPSCs (right) and eGFPAID ESCs (bottom) before and 1.5 hours after addition of IAA. ChIP-qPCR data 
represent the mean ± SD of three IPs for H3K27ac, and the mean of three technical replicates of a single 
IP for IgG. ND = not detected. D) Violin and box plot showing H3K27ac signal before and 1.5 hours after 
addition of IAA at all detected H3K27ac peaks. Peaks with signal below the indicated threshold both 
before and after induction were consider to be background and were excluded from further analysis. E) 
Violin plot showing log2-fold change in H3K27ac signal between uninduced and 1.5 hour IAA treated 





















































































Figure S4. Analysis of Oct4 and Nanog following induction. Relating to Figure 4. 
A) ChIP-Western for Oct4AID in O4AID ESCs, either uninduced or following 1.5 hours of treatment with 
IAA. Input samples were taken from sheared, crosslinked chromatin prior to immunoprecipitation. Input 
was diluted so that one tenth the amount was loaded compared to IP samples. Note, a high molecular 
weight band in the uninduced pull-down lane likely represents Oct4 still bound to chromatin due to 
incomplete reverse crosslinking. Non-neighbouring lanes from the same blot have been aligned for 
comparison (full blot in B)). B) Complete blot that lanes in A) are taken from. C-D) Analysis of Nanog 
binding to pluripotent regulatory sequences in O4AID iPSCs. C) Protein level of Oct4 and Nanog 
(Western blot) in O4AID iPSCs before and 2 hours after addition of IAA with α-tubulin as a loading 
control. D) ChIP qPCR following pulldown of Nanog or using normal IgG negative control at Nanog 
binding sites or a negative control locus in O4AID iPSCs. Nanog pulldown represents mean ± SD of three 
IPs; IgG pulldown represents the mean of three technical replicates of a single IP. 
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Figure S5. Analysis of Nanog stability and global chromatin binding. Relating to Figure 5. 
A&B) Analysis of Nanog protein half-life in O4AID ES with and without Oct4 depletion. A) Western blot 
analysis of Nanog protein level in a timecourse following cycloheximide treatment, with or without addition 
of IAA. Standard curve is equivalent to 1X 0h uninduced sample, 0.5X, 0.25X, 0.125X. B) Plot of natural 
log of Nanog protein quantity against time used to calculate the decay constant, λ, from the equation 
ln(x(t)) = ln(x0) + λt. From this, the protein half-life is calculated as t1/2 = ln(2)/λ. C) Violin and box plot 
showing Nanog signal before and 1.5 hours after addition of IAA at all detected Nanog peaks. Peaks with 
signal below the indicated threshold both before and after induction were consider to be background and 
were excluded from further analysis. D) Violin plot showing log2-fold change in Nanog signal between 
uninduced and 1.5 hour IAA treated O4AID ESCs at the peaks below the threshold indicated in C). 
 
Supplemental Experimental Procedures 
Chromatin immunoprecipitation 
Briefly, 10×106 cells per IP for transcription factors or 5×106 cells per IP for histone modifications were 
fixed for 10 min in 1% formaldehyde. Fixation was halted by addition of an excess of glycine. Cells 
were washed with ice-cold PBS. Nuclei were isolated: Cells were incubation with Lysis Buffer 1 (50 
mM HEPES pH 7.5, 140 mM NaCl,1 mM EDTA, 10% Glycerol, 0.5% NP40, 0.25% Tx100) at 4 °C for 
10 mins, pelleted, then incubated with Lysis Buffer 2 (10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 
0.5 mM EGTA) at 4 °C for 10 mins. Nuclei were pelleted then resuspended in Shearing Buffer (50 mM 
Tris pH 8.0, 1% SDS, 10 mM EDTA) and sonicated to obtain an average DNA fragment size of 500 
base pairs. Lysates were diluted 1:10 in dilution buffer (50 mM Tris–HCl at pH 8.0, 167 mM NaCl, 
1.1% Triton X-100 and 0.11% sodium deoxycholate) and pre-cleared for 2 h at 4 °C with Dynabeads 
Protein G magnetic beads (Invitrogen) that were pre-incubated with isotypic IgG antibody. 
Supernatent was collected, a 10% input sample was taken for relative quantitation, and the chromatin 
was the incubated overnight at 4 °C with 2 μg of antibody or 2 μg of isotypic IgG control. Lysates were 
then incubated for 1 h at 4 °C with BSA-blocked Dynabeads Protein G magnetic beads, and the beads 
were washed twice in wash buffer 1 (50 mM Tris pH 8.0, 0.1% SDS, 0.1% Sodium deoxycholate, 1% 
Tx100, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA), once in Wash Buffer 2 (50 mM Tris pH 8.0, 0.1% 
SDS, 0.1% sodium deoxycholate, 1% Tx100, 500 mM NaCl, 1 mM EDTA, 0.5 mM EGTA), once in 
Wash Buffer 3 (50 mM Tris pH 8.0, 250 mM LiCl, 0.5% Sodium deoxycholate, 0.5% NP40, 1 mM 
EDTA, 0.5 mM EGTA) and twice in wash buffer 4 (50 mM Tris pH 8.0, 10 mM EDTA and 5 mM 
EGTA). Chromatin was eluted twice for a total of 30 min at 65 °C in elution buffer (1% SDS and 0.1 M 
NaHCO3). NaCl was added to samples and inputs to a final concentration of 200 mM, before 
incubating overnight at 65 °C to reverse the crosslinking and DNA was purified using the QIAquick 
PCR Purification kit (Qiagen). 
ChIP-seq analysis 
Normalized enrichment tracks were generated from aligned reads with the MACS2 (Liu, 2014) 
callpeak function using the –SPMR flag. H3K27ac peaks were called using MACS2 callpeak function 
on pooled mapped reads of 3 independent IPs from uninduced samples. For analysis of H3K27ac 
signal intensity, mapped reads from 3 independent IPs were pooled and RPKM normalized using 
DiffBind (Stark and Brown, 2017). Peaks with RPKM < 0.5 in both uninduced and induced samples 
were considered to be background and excluded from further analysis. Subsets of peaks located 
within 1kb of Oct4 peaks were determined by analysis of published ChIP-seq data; reads were 
deduplicated and aligned as above, and peaks were called using MACS2 callpeak function with whole 
cell extract used as control samples. 
Nanog peaks were called from aligned reads using MACS2 callpeak function on pooled ChIP-seq 
data from two independent IPs each from both uninduced and IAA treated samples. For analysis of 
Nanog signal at binding sites, mapped reads from two independent IPs each of treated and untreated 
samples were pooled and RPKM normalized using deepTools2 (Ramírez et al., 2016) bamCoverage 
and blacklisted regions from the ENCODE project consortium were excluded, then a heatmap and 
summary plot were generated using deepTools2 computeMatrix and plotHeatmap tools. For pairwise 
analysis of Nanog binding at peaks called from pooled data from both uninduced and IAA treated 
samples, centred on the peak summit and extending a total of 350bp, replicates were pooled and 
RPKM normalized using DiffBind. Peaks with an RPKM < 0.9 in both uninduced and induced samples 
were considered to be background and excluded from further analysis. Subsets of peaks 
corresponding to active promoters, active enhancers and repressed regions were assigned using 
published ChIP-seq peaksets from ENSEMBL, using the following criteria: active promoters, within 
1kb of PolII and either overlapping H3K4me1 or H3K4me3; active enhancer, within 1kb of P300 and 
overlapping H3K27ac; repressed region, overlapping either H3K9me3 or H3K27me3. 
Public datasets used 
Dataset Source Analysis 
Bruce4 ES EP300 ChIP-seq peakset Ensembl (release 100) SWEmbl 
Bruce4 ES PolII ChIP-seq peakset Ensembl (release 100) SWEmbl 
Bruce4 ES H3K27ac ChIP-seq peakset Ensembl (release 100) SWEmbl 
Bruce4 ES H3K27me3 ChIP-seq 
peakset 
Ensembl (release 100) CCAT 
Bruce4 ES H3K4me1 ChIP-seq peakset Ensembl (release 100) CCAT 
Bruce4 ES H3K4me3 ChIP-seq peakset Ensembl (release 100) SWEmbl 
Bruce4 ES H3K9me3 ChIP-seq peakset Ensembl (release 100) CCAT 




V6.5 ES whole cell extract data Marson et al. 2008, GEO accessions 





Target Source Catalogue number 
Polyclonal goat anti-Oct4 Santa Cruz Biotechnology sc-8628 
Monoclonal mouse anti-alpha-Tubulin Abcam ab7291 
Polyclonal rabbit anti-H3K27ac Abcam ab4729 
Monoclonal rat anti-Nanog eBioscience 14-5761-80 
Monoclonal rat anti-Sox2 eBioscience 14-9811-80 
 
qPCR primers and probesets 
Target Use Source Catalogue number / sequence 
Oct4 RT-qPCR ThermoFisher 
Scientific 
Mm00658129_gH 
Nanog RT-qPCR ThermoFisher 
Scientific 
Mm02384862_g1 
Rex1 RT-qPCR ThermoFisher 
Scientific 
Mm03053975_g1 
Klf4 RT-qPCR ThermoFisher 
Scientific 
Mm00516104_m1 
Lifr RT-qPCR ThermoFisher 
Scientific 
Mm00442942_m1 
Nr0b1 RT-qPCR ThermoFisher 
Scientific 
Mm00431729_m1 
Cdx2 RT-qPCR ThermoFisher 
Scientific 
Mm01212280_m1 
Elf5 RT-qPCR ThermoFisher 
Scientific 
Mm00468732_m1 
Krt7 RT-qPCR Sigma Aldrich MMUS_NM_033073_1 
Gata6 RT-qPCR ThermoFisher 
Scientific 
Mm00802636_m1 
Pax6 RT-qPCR ThermoFisher 
Scientific 
Mm00443081_m1 
T RT-qPCR ThermoFisher 
Scientific 
Mm01318252_m1 
Gata4 RT-qPCR ThermoFisher 
Scientific 
Mm00484689_m1 
Ascl1 RT-qPCR ThermoFisher 
Scientific 
Mm03058063_m1 
Zeb2 RT-qPCR ThermoFisher 
Scientific 
Mm00497193_m1 
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